-
After Randy Pitchford had a game cancelled by EA, he was called by Gabe Newell out of nowhere to ask if he wanted to work on Half-Life: "I don't believe in manifestation - I believe in coincidence"
26 Oct 2025 12:02 GMT
… faced the same fate "Half-Life had just launched, and so … be interested in working on Half-Life." He "immediately … game that would eventually become Half-Life: Opposing Force. However, since … Valve didn't own Half-Life at that point, with …
-
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
24 Oct 2025 17:15 GMT
… Impact on F508del-CFTR Half-Life In a poster presented … SION-451 increased the half-life of mature F508del-CFTR … and impaired CFTR folding, trafficking, half-life, and function,” said Dr. … rate of degradation and decreased half-life relative to wild-type …
-
The Half Life Reexamines an 'Idyllic' Sardinia Childhood — See the Cover! (Exclusive) By Lindsay Kimble
23 Oct 2025 18:14 GMT
… for her upcoming novel, The Half Life.
PEOPLE has an exclusive first … at the cover of The Half Life, set for release this … — than I realized."
The Half Life.
Simon & Schuster
Like Beanland … s prolonged absences."
The Half Life comes out July 14, …
-
<![CDATA[MARIPOSA-2 Toxicity Management: Amivantamab Delay vs Dose Reduction]]>
27 Oct 2025 20:01 GMT
… , particularly because amivantamab’s long half-life means adverse effects build gradually …
-
Creative Biolabs' integrated drug analysis solutions
27 Oct 2025 19:38 GMT
… to assess metabolic rate and half-life
Plasma protein binding assay: Determining …
-
ORIC® Pharmaceuticals Presented Preclinical Data at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics Supporting Best-in-Class Potential of ORIC-944 to Treat Patients With Prostate Cancer and Other Solid Tumors
27 Oct 2025 12:30 GMT
… potency, solubility, and pharmacokinetics, with half-life supporting once daily dosing. ORIC … -class drug properties, including clinical half-life of approximately 20 hours, robust …
-
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
27 Oct 2025 12:00 GMT
… Allergy Institute, added, “As a half-life extended anti-IgE monoclonal antibody … RPT904)
Ozureprubart is a novel, half-life extended anti-IgE bio-better …
-
Borderlands 4 Chief Randy Pitchford Thinks The Games Industry Is Just Getting Started
27 Oct 2025 09:43 GMT
… , we name the likes of Half-Life 2, Baldur's Gate …
-
Oak Ridge engineer seeks to help make interstellar travel possible
27 Oct 2025 08:56 GMT
… nuclear fission that has a half-life of about 29 years, decays …
-
A Comprehensive Analysis of Teicoplanin Population Pharmacokinetic Models in Pediatric Populations: Age-Dependent Variability and Implications for Dose Optimization
27 Oct 2025 06:50 GMT
… . The drug exhibits a long half-life, enabling less frequent dosing; however …